|

Ameluz 10% Topical Gel Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ALA gel

Pipeline

Phase 4: 1

Top Sponsors

  • Psoriasis Treatment Center of Central New Jersey1
  • Dartmouth-Hitchcock Medical Center1

Indications

  • Cancer2
  • Benign Skin Growth1
  • Non-Melanoma Skin Cancer (NMSC)1
  • Actinic Keratoses1

Lebanon, New Hampshire1 trial

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Dartmouth Hitchcock

East Windsor, New Jersey1 trial

Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face

Psoriasis Treatment Center of New Jersey

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.